EU panel finds no link between GSK's Pandemrix and narcolepsy

09/23/2010 | Reuters

A committee of the European Medicines Agency found no sufficient evidence that Pandemrix, an H1N1 flu vaccine by GlaxoSmithKline, causes narcolepsy, a rare sleeping disorder. "The committee concluded that the available evidence was insufficient to determine whether there is any link between Pandemrix and reports of narcolepsy, and that further studies were necessary to fully understand this issue," the agency said.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA